Both H1299, a p53-null non-small cell lung cancer (NSCLC), and MDA-MB-231, triple negative breast cancer cell, are less sensitive to TGF-β1 but they undergo substantially the EMT process in response to TGF-β1 [59,62]. The gene discussed is TP53; the disease is triple-negative breast carcinoma.